Trial Profile
A study investigating the effect of everolimus eluting platinum chromium stent (Promus Element) in Swedish Coronary Angiography and Angioplasty Registry patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- 15 Dec 2015 New trial record